Apmis最新文献

筛选
英文 中文
Association of TLR4 polymorphisms (Asp299Gly and Thr399Ile) with sepsis: a meta-analysis and trial sequence analysis TLR4 多态性(Asp299Gly 和 Thr399Ile)与败血症的关系:荟萃分析和试验序列分析。
IF 2.2 4区 医学
Apmis Pub Date : 2024-09-02 DOI: 10.1111/apm.13463
Jingjing Mu, Yue Shen, Furong Zhu, Qixia Zhang
{"title":"Association of TLR4 polymorphisms (Asp299Gly and Thr399Ile) with sepsis: a meta-analysis and trial sequence analysis","authors":"Jingjing Mu,&nbsp;Yue Shen,&nbsp;Furong Zhu,&nbsp;Qixia Zhang","doi":"10.1111/apm.13463","DOIUrl":"10.1111/apm.13463","url":null,"abstract":"<p>Several investigations have been carried out to explore the genetic association of TLR4 codon variants, specifically Asp299Gly and Thr399Ile, and susceptibility to sepsis, but the results have been contradictory. The present study aimed to conduct a meta-analysis to draw a definitive conclusion regarding the role of TLR4 genetic variants (Asp299Gly and Thr399Ile) in sepsis. A thorough literature search was conducted using the PubMed, Scopus, and Science Direct databases. The inclusion and exclusion criteria were established to ensure the accuracy of the data. The Comprehensive Meta-Analysis Software v4 was utilized to perform the meta-analysis and related analyses. A total of 13 studies were analyzed, including 2328 sepsis cases and 2495 healthy controls for the TLR4 Asp299Gly variant. Eight studies provided genotype data for the rs4986791 polymorphism. The Asp299Gly variant showed a marginal protective effect in the allele (p = 0.08, odds ratio = 0.71) and dominant (p = 0.09, odds ratio = 0.71) genetic models, although it was not statistically significant. The trial sequential analysis indicated that further case–control studies are necessary to draw definitive conclusions about the TLR4 polymorphisms in sepsis. The TLR4 Asp299Gly variant may have a protective effect against sepsis. However, additional research with larger sample sizes across diverse populations is required to validate this finding.</p>","PeriodicalId":8167,"journal":{"name":"Apmis","volume":"132 11","pages":"869-880"},"PeriodicalIF":2.2,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142118861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HERC5: a comprehensive in silico analysis of its diagnostic, prognostic, and therapeutic potential in cancer HERC5:对其在癌症诊断、预后和治疗方面潜力的全面硅学分析。
IF 2.2 4区 医学
Apmis Pub Date : 2024-08-28 DOI: 10.1111/apm.13462
Xianqing Sun, Peng Qiu, Zhennan He, Yuan Zhu, Rui Zhang, Xiang Li, Xiaoyan Wang
{"title":"HERC5: a comprehensive in silico analysis of its diagnostic, prognostic, and therapeutic potential in cancer","authors":"Xianqing Sun,&nbsp;Peng Qiu,&nbsp;Zhennan He,&nbsp;Yuan Zhu,&nbsp;Rui Zhang,&nbsp;Xiang Li,&nbsp;Xiaoyan Wang","doi":"10.1111/apm.13462","DOIUrl":"10.1111/apm.13462","url":null,"abstract":"<p>HERC5, a vital protein in the HERC family, plays crucial roles in immune response, cancer progression, and antiviral defense. This bioinformatic study comprehensively assessed HERC5's significance across various malignancies by analyzing its gene expression, immune and molecular subtype expressions, target proteins, biological functions, and prognostic and diagnostic values in pan-cancer. We further examined its correlation with clinical features, co-expressed and differentially expressed genes, and prognosis in clinical subgroups, focusing on endometrial cancer (UCEC). Our findings showed that HERC5 RNA is expressed at low levels in most cancers and significantly differs across immune and molecular subtypes. HERC5 accurately predicts cancer and correlates with most cancer prognoses. In UCEC, HERC5 was significantly associated with age, hormonal status, clinical stage, treatment status, and metastasis. Elevated HERC5 expression was linked to worse progression-free interval, disease-specific survival, and overall survival in UCEC, particularly in diverse clinical subgroups. Significant differences in HERC5 expression were also observed in various human cancer cell line validations. In summary, HERC5 may be a critical biomarker for pan-cancer prognosis, progression, and diagnosis, as well as a promising new target for cancer therapy.</p>","PeriodicalId":8167,"journal":{"name":"Apmis","volume":"132 11","pages":"760-774"},"PeriodicalIF":2.2,"publicationDate":"2024-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/apm.13462","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142091711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Forssman and the staphylococcal hemolysins 福斯曼和葡萄球菌溶血素
IF 2.2 4区 医学
Apmis Pub Date : 2024-08-27 DOI: 10.1111/apm.13459
Hanne Ingmer, Jørgen J. Leisner, Stephanie Fulaz
{"title":"Forssman and the staphylococcal hemolysins","authors":"Hanne Ingmer,&nbsp;Jørgen J. Leisner,&nbsp;Stephanie Fulaz","doi":"10.1111/apm.13459","DOIUrl":"10.1111/apm.13459","url":null,"abstract":"<p>Forssman was a Swedish pathologist and microbiologist who, in the 1920s and 1930s conducted a long series of experiments that led to unique insights into surface antigens of blood cells, as well as added to the discrimination of toxins produced by staphylococci that lyse red blood cells. This review takes offset in the studies published by Forssman in APMIS addressing the hemolytic properties of staphylococcal toxins displayed against erythrocytes of animal and human origin. In light of current knowledge, we will discuss the insights we now have and how they may pave the way for curing infections with pathogenic staphylococci, including <i>Staphylococcus aureus</i>.</p>","PeriodicalId":8167,"journal":{"name":"Apmis","volume":"133 1","pages":""},"PeriodicalIF":2.2,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11669744/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142071865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to “Comment on micro- and nanorobots for biofilm eradication” 回复 "关于用于消除生物膜的微型和纳米机器人的评论"。
IF 2.2 4区 医学
Apmis Pub Date : 2024-08-13 DOI: 10.1111/apm.13460
Naji Naseef Pathoor, Pitchaipillai Sankar Ganesh
{"title":"Reply to “Comment on micro- and nanorobots for biofilm eradication”","authors":"Naji Naseef Pathoor,&nbsp;Pitchaipillai Sankar Ganesh","doi":"10.1111/apm.13460","DOIUrl":"10.1111/apm.13460","url":null,"abstract":"","PeriodicalId":8167,"journal":{"name":"Apmis","volume":"132 11","pages":"757-758"},"PeriodicalIF":2.2,"publicationDate":"2024-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141974949","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
RE: Aetiological profile of acute encephalitis syndrome in Assam, India, during a 4-year period from 2019 to 2022 RE:2019年至2022年4年间印度阿萨姆邦急性脑炎综合征的病原学概况。
IF 2.2 4区 医学
Apmis Pub Date : 2024-08-13 DOI: 10.1111/apm.13461
Hinpetch Daungsupawong, Viroj Wiwanitkit
{"title":"RE: Aetiological profile of acute encephalitis syndrome in Assam, India, during a 4-year period from 2019 to 2022","authors":"Hinpetch Daungsupawong,&nbsp;Viroj Wiwanitkit","doi":"10.1111/apm.13461","DOIUrl":"10.1111/apm.13461","url":null,"abstract":"","PeriodicalId":8167,"journal":{"name":"Apmis","volume":"132 11","pages":"759"},"PeriodicalIF":2.2,"publicationDate":"2024-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141970517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Decreased T-cell response against latent cytomegalovirus infection does not correlate with anti-IFN autoantibodies in patients with APECED 在 APECED 患者中,针对潜伏巨细胞病毒感染的 T 细胞反应降低与抗 IFN 自身抗体无关。
IF 2.2 4区 医学
Apmis Pub Date : 2024-08-07 DOI: 10.1111/apm.13458
Iivo Hetemäki, Nelli Heikkilä, Pärt Peterson, Eliisa Kekäläinen, Nick Willcox, Wolff Anette S. B., Hanna Jarva, T Petteri Arstila
{"title":"Decreased T-cell response against latent cytomegalovirus infection does not correlate with anti-IFN autoantibodies in patients with APECED","authors":"Iivo Hetemäki,&nbsp;Nelli Heikkilä,&nbsp;Pärt Peterson,&nbsp;Eliisa Kekäläinen,&nbsp;Nick Willcox,&nbsp;Wolff Anette S. B.,&nbsp;Hanna Jarva,&nbsp;T Petteri Arstila","doi":"10.1111/apm.13458","DOIUrl":"10.1111/apm.13458","url":null,"abstract":"<p>Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) is an inborn error of immunity affecting both multiple endocrine organs and susceptibility to candidiasis, each with an autoimmune basis. Recently, high titer neutralizing anti-type I interferon (IFN) autoantibodies have been linked with increased severity of SARS-CoV-2 and <i>varicella zoster</i> virus infections in APECED patients. Examining immunity against cytomegalovirus (CMV), we found a higher prevalence of anti-CMV IgG antibodies in patients with APECED (N = 19) than in 44 healthy controls (90% vs 64%, p = 0.04); the similar difference in their IgG levels did not achieve significance (95 ± 74 vs 64 ± 35 IU/mL, ns.). In contrast, the frequency of CMV-specific T cells was lower (804 ± 718/million vs 1591 ± 972/million PBMC p = 0.03). We saw no correlations between levels of anti-CMV IgG and anti-IFN antibodies in APECED patients or in a separate cohort of patients with thymoma (n = 70), over 60% of whom also had anti-IFN antibodies. Our results suggest a dysregulated response to CMV in APECED patients and highlight immunodeficiency to viral infections as part of the disease spectrum.</p>","PeriodicalId":8167,"journal":{"name":"Apmis","volume":"132 11","pages":"881-887"},"PeriodicalIF":2.2,"publicationDate":"2024-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/apm.13458","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141900759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-world data confirm elexacftor/tezacaftor/ivacaftor modulators halves sweat chloride concentration in eligible people with cystic fibrosis 真实世界的数据证实,elexacftor/tezacaftor/ivacaftor调节剂可将符合条件的囊性纤维化患者的汗液氯化物浓度减半。
IF 2.2 4区 医学
Apmis Pub Date : 2024-08-02 DOI: 10.1111/apm.13453
Thomas Bryrup, Daniel Faurholt-Jepsen, Tacjana Pressler, Esben Herborg Henriksen, Christian Leo-Hansen, Bibi Uhre Nielsen, Christine Højte, Inger Hee Mabuza Mathiesen, Terese L. Katzenstein, Majbritt Jeppesen, Søren Jensen-Fangel, Hanne Vebert Olesen, Marianne Skov, Tavs Qvist, Mette Frahm Olsen, the TransformCF Study Group
{"title":"Real-world data confirm elexacftor/tezacaftor/ivacaftor modulators halves sweat chloride concentration in eligible people with cystic fibrosis","authors":"Thomas Bryrup,&nbsp;Daniel Faurholt-Jepsen,&nbsp;Tacjana Pressler,&nbsp;Esben Herborg Henriksen,&nbsp;Christian Leo-Hansen,&nbsp;Bibi Uhre Nielsen,&nbsp;Christine Højte,&nbsp;Inger Hee Mabuza Mathiesen,&nbsp;Terese L. Katzenstein,&nbsp;Majbritt Jeppesen,&nbsp;Søren Jensen-Fangel,&nbsp;Hanne Vebert Olesen,&nbsp;Marianne Skov,&nbsp;Tavs Qvist,&nbsp;Mette Frahm Olsen,&nbsp;the TransformCF Study Group","doi":"10.1111/apm.13453","DOIUrl":"10.1111/apm.13453","url":null,"abstract":"<p>Sweat chloride concentration, a diagnostic feature in cystic fibrosis (CF), reflects CF transmembrane conductance regulator (CFTR) activity. CFTR modulator therapies, especially elexacaftor/tezacaftor/ivacaftor (ETI), has improved CF outcomes. We report nationwide, real-world data on sweat chloride concentration in people with CF (pwCF) with and without modulator therapies. All Danish pwCF with a minimum of one F508del allele were included. Sweat chloride measurements were stratified by genotype and modulator treatment. Differences were assessed using mixed-effects models. We included 977 sweat chloride measurements from 430 pwCF, 71% of which were F508del homozygous. Heterozygous and homozygous ETI-treated pwCF had an estimated mean sweat chloride concentration of 43 mmol/L (95% confidence interval: 39; 48) and 43 mmol/L (39; 47), respectively—48% and 59% lower than those without treatment. High variation in concentrations remained regardless of treatment status. Despite ETI treatment, 27% heterozygous and 23% homozygous pwCF had elevated concentrations (≥60 mmol/L). These real-world data confirm a substantial decrease in sweat chloride concentration during modulator treatment, especially ETI, where mean concentrations halved. However, large variation remained, including persistently high concentrations. These findings emphasize the potential of sweat chloride concentration as a treatment response biomarker and the need to explore its heterogeneity and relationship with clinical outcomes.</p>","PeriodicalId":8167,"journal":{"name":"Apmis","volume":"132 10","pages":"728-733"},"PeriodicalIF":2.2,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/apm.13453","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141873988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A mathematical description of nonself for biallelic genetic systems in pregnancy, transfusion, and transplantation 妊娠、输血和移植中的双偶联遗传系统的非自我数学描述。
IF 2.2 4区 医学
Apmis Pub Date : 2024-07-19 DOI: 10.1111/apm.13457
Klaus Rieneck
{"title":"A mathematical description of nonself for biallelic genetic systems in pregnancy, transfusion, and transplantation","authors":"Klaus Rieneck","doi":"10.1111/apm.13457","DOIUrl":"10.1111/apm.13457","url":null,"abstract":"<p>A central issue in immunology is the immunological response against nonself. The prerequisite for a specific immunological response is the exposure to the immune system of a nonself antigen. Mathematical equations are presented, which define the fraction of all outcomes with a nonself allele in biallelic systems at the population level in pregnancy and transfusion/transplantation medicine. When designing assays, the mathematical descriptions can be used for estimating the number of genetic markers necessary to obtain a predetermined probability level in detecting nonself alleles of a given frequency. For instance, the equations can be helpful in the design of assays, where the nonself allele can be detected by analysis of cfDNA in plasma from pregnant women, to estimate fetal fraction or to monitor changes in cfDNA in plasma of transplantation patients. The equations give exact, quantitative descriptions of all nonself situations in pregnancy and transfusion/transplantation.</p>","PeriodicalId":8167,"journal":{"name":"Apmis","volume":"132 11","pages":"787-796"},"PeriodicalIF":2.2,"publicationDate":"2024-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/apm.13457","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141730988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the role of mesenchymal stem cells in modulating immune responses via Treg and Th2 cell activation: insights from mouse model of multiple sclerosis 探索间充质干细胞在通过Treg和Th2细胞激活调节免疫反应中的作用:多发性硬化症小鼠模型的启示。
IF 2.2 4区 医学
Apmis Pub Date : 2024-07-19 DOI: 10.1111/apm.13456
Abdolvahid Sadeghnejad, Alireza Pazoki, Esmaeil Yazdanpanah, Seyed-Alireza Esmaeili, Bahman Yousefi, Bijan Sadighi-Moghaddam, Rasoul Baharlou, Dariush Haghmorad
{"title":"Exploring the role of mesenchymal stem cells in modulating immune responses via Treg and Th2 cell activation: insights from mouse model of multiple sclerosis","authors":"Abdolvahid Sadeghnejad,&nbsp;Alireza Pazoki,&nbsp;Esmaeil Yazdanpanah,&nbsp;Seyed-Alireza Esmaeili,&nbsp;Bahman Yousefi,&nbsp;Bijan Sadighi-Moghaddam,&nbsp;Rasoul Baharlou,&nbsp;Dariush Haghmorad","doi":"10.1111/apm.13456","DOIUrl":"10.1111/apm.13456","url":null,"abstract":"<p>Multiple sclerosis is a demyelinating neurodegenerative disease, and its animal model, experimental autoimmune encephalomyelitis (EAE), exhibits immunological and clinical similarities. The study aimed to examine mechanisms underlying therapeutic effects of mesenchymal stem cell administration in EAE. C57BL/6 mice were separated into control and treatment groups (T1, T2, and T3); EAE was induced in all animals. Clinical examinations were conducted daily, and on 25th day, animals were sacrificed, and spinal cord was stained for histological analysis. Additionally, spleen cell proliferation assay, assessments of cytokine, and gene expression in both spinal cord and spleen cells were performed. The results indicated a significant reduction in clinical symptoms among treatment groups compared to control group. Histological analyses revealed decreased infiltration of lymphocytes into the spinal cord and reduced demyelinated areas in treatment groups compared to control group. Cytokine production of IL-10, TGF-β, and IL-4 were significantly enhanced and IFN-γ and TNF-α in treatment groups were decreased relative to control group. Also, gene expression of CTLA-4, PD-1, IL-27, and IL-33 indicated a significant increase in treatment groups. The administration of MSCs significantly improved clinical symptoms, attenuated inflammation, and reduced spinal cord demyelination in EAE, suggesting a potential protective effect on disease progression.</p>","PeriodicalId":8167,"journal":{"name":"Apmis","volume":"132 11","pages":"888-899"},"PeriodicalIF":2.2,"publicationDate":"2024-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141730989","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unravelling the intricacies of Porphyromonas gingivalis: virulence factors, lifecycle dynamics and phytochemical interventions for periodontal disease management 揭开牙龈卟啉单胞菌的神秘面纱:毒力因子、生命周期动态和牙周病管理的植物化学干预措施。
IF 2.2 4区 医学
Apmis Pub Date : 2024-07-19 DOI: 10.1111/apm.13440
Rubeen Nadaf, Vijay M. Kumbar, Shridhar Ghagane
{"title":"Unravelling the intricacies of Porphyromonas gingivalis: virulence factors, lifecycle dynamics and phytochemical interventions for periodontal disease management","authors":"Rubeen Nadaf,&nbsp;Vijay M. Kumbar,&nbsp;Shridhar Ghagane","doi":"10.1111/apm.13440","DOIUrl":"10.1111/apm.13440","url":null,"abstract":"<p><i>Porphyromonas gingivalis</i> is a gram-negative anaerobic bacterium recognized for its pivotal role in the pathogenesis of periodontal diseases. This review covers an overview of the virulence factors and lifecycle stages of <i>P. gingivalis</i>, with a specific focus on attachment and colonization, biofilm formation, growth and multiplication, dormancy survival and dissemination. Additionally, we explore the significance of inter-bacterial cross-feeding within biofilms. Furthermore, we discuss potential phytochemical-based strategies to target <i>P. gingivalis</i>, including the use of curcumin, apigenin, quercetin and resveratrol. Understanding the virulence factors and lifecycle stages of <i>P. gingivalis</i>, along with the promising phytochemical-based interventions, holds promise for advancing strategies in periodontal disease management and oral health promotion.</p>","PeriodicalId":8167,"journal":{"name":"Apmis","volume":"132 9","pages":"611-624"},"PeriodicalIF":2.2,"publicationDate":"2024-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141730990","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信